2011
DOI: 10.1186/1478-7547-9-10
|View full text |Cite
|
Sign up to set email alerts
|

Insomnia - treatment pathways, costs and quality of life

Abstract: BackgroundInsomnia is perhaps the most common sleep disorder in the general population, and is characterised by a range of complaints around difficulties in initiating and maintaining sleep, together with impaired waking function. There is little quantitative information on treatment pathways, costs and outcomes. The aims of this New Zealand study were to determine from which healthcare practitioners patients with insomnia sought treatment, treatment pathways followed, the net costs of treatment and the qualit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
20
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(20 citation statements)
references
References 18 publications
0
20
0
Order By: Relevance
“…29,30 Walsh 3 has demonstrated that direct costs for the management of insomnia have been estimated to be USD13.9 billion annually, and successful treatment of insomnia has been indicated to be correlated with direct cost savings and improved quality of life. 31 However, the saving observed from the latter study seemed not so significant, probably due to additional expenses that might arise from the psychoactive nature of most medications for the treatment of sleep disorder. The use of safe and effective plant-derived substances to manage sleep disorder might have additional benefits economically.…”
Section: Discussionmentioning
confidence: 82%
“…29,30 Walsh 3 has demonstrated that direct costs for the management of insomnia have been estimated to be USD13.9 billion annually, and successful treatment of insomnia has been indicated to be correlated with direct cost savings and improved quality of life. 31 However, the saving observed from the latter study seemed not so significant, probably due to additional expenses that might arise from the psychoactive nature of most medications for the treatment of sleep disorder. The use of safe and effective plant-derived substances to manage sleep disorder might have additional benefits economically.…”
Section: Discussionmentioning
confidence: 82%
“…Moreover, the number of evidence showing the relationship between insomnia and other public health issues such as depression, accidents and anxiety is steadily increasing (Léger & Bayon, 2010;Roth, 2007;Crowley, 2011). Approximately 20% of all motor vehicle accidents are associated with driver sleepiness (independent of alcohol) (Scott, et al, 2011). Sleep apnea, restless leg syndrome, shift work sleep disorders, hypersomnia have also been proved to have an important impact from a socio-economic perspective (Léger & Bayon, 2010;Roth, 2007;Crowley, 2011).…”
Section: Quality Of Life In the Management Of Insomniamentioning
confidence: 99%
“…Patients' family and colleagues could also be negatively affected by insomnia. There are many studies in the medical literature showing that treating sleep disorders increase quality of life (Moyer, et al, 2001;Scott, et al, 2011). Protective measures should be taken in order to underscore the benefits of a good night's sleep and to ensure regular sleep among high-risk individuals.…”
Section: Quality Of Life In the Management Of Insomniamentioning
confidence: 99%
See 1 more Smart Citation
“…Moreover, insomnia goes along with aggravating consequences in daily life, such as fatigue, lack of concentration, irritability, and decline in energy [3]. The reduced quality of sleep has an impact on various physiological and functional conditions [4]. It affects quality of life and the occupational situation of those affected and may therefore require additional health care services [5,6].…”
Section: Introductionmentioning
confidence: 99%